Todas as matérias desta categoria, das mais recentes às mais antigas.
Beam Global (NASDAQ:BEEM) announced that it has entered into a non-binding Letter of Intent to acquire a European drone technology company specializing in drone development, manufacturing and AI-enhanced drone software.
Summit Therapeutics (NASDAQ:SMMT) announced that data from the Phase III HARMONi-GI1 trial evaluating ivonescimab, a potential first-in-class investigational bispecific antibody, will be presented at the Presidential Symposium II during the European Society for Medical Oncology (ESMO) 2026 Congress.
Vicor Corporation (NASDAQ:VICR) shares moved higher in premarket trading after the modular power components manufacturer raised its third-quarter growth outlook, citing royalty income from a recently announced licensing agreement.
Brent fell toward $99 a barrel, after tumbling over the previous four sessions. Oil erased earlier gains on a report that Iran could reopen the Strait of Hormuz if the US lifted a blockade of its ports. US President Donald Trump is set to address the United Nations General Assembly in New York later, and he may meet with his Iranian counterpart, Masoud Pezeshkian. Bloomberg's Will Kennedy breaks down the situation.
Here Group (NASDAQ:HERE) reported unaudited financial results for the fourth quarter and full fiscal year ended June 30, 2026, highlighting revenue growth from its expanding pop toy business and announcing corporate leadership changes.
TC Energy (NYSE:TRP) announced an agreement to sell Energía Occidente de México, the owner of the Guadalajara-Manzanillo Pipeline, to affiliates of ESENTIA for approximately $560 million.
Kanzhun (NASDAQ:BZ) announced that its board of directors has declared an annual cash dividend totaling approximately US$230 million to shareholders.
KKR (NYSE:KKR) and Mirastar, KKR Real Estate’s European industrial and logistics platform, have acquired a portfolio of eight UK logistics assets from funds managed by Ares Management Corporation Real Estate.
Pharming Group (NASDAQ:PHAR) announced positive topline results from a Phase II study evaluating leniolisib in patients with genetically identifiable primary immunodeficiencies (PIDs) associated with immune dysregulation caused by PI3Kδ signaling abnormalities.
AbbVie (NYSE:ABBV) announced that the European Commission has approved RINVOQ® (upadacitinib) 15 mg tablets and 1 mg/mL oral solution for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA).
Anwiti Bahuguna, global co-chief investment officer at Northern Trust Asset Management, discusses the artificial intelligence trade, and says US stocks are undervalued based on the earnings picture. "You buy more stocks in that environment," she tells Bloomberg Television.
Novo CEO Mike Doustdar discusses investor confidence, drug testing and the potential for expanding the firm's obesity offerings. "We should also have a mindset that we don't have a patent or a monopoly on all the good ideas," Doustdar tells Bloomberg Television. "When there is a gap, strategically or scientifically, we're looking outside to see how we can fill the gaps."
